malignant melanoma and cdkn2a kate coffin

47
Malignant Melanoma and CDKN2A Kate Coffin http://www.liuding.com/blog/uploaded_images/ fig8-794407.jpg

Upload: elmer-atkins

Post on 24-Dec-2015

216 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Malignant Melanoma and CDKN2A Kate Coffin

Malignant Melanoma and CDKN2A

Kate Coffin

http://www.liuding.com/blog/uploaded_images/fig8-794407.jpg

Page 2: Malignant Melanoma and CDKN2A Kate Coffin

MelanomaGenetics and Environment

Skin cancer of melanocytes

Pre-existing nevus or new nevus

Different areas of skin

ABCDE assessment system of skin

http://www.aad.org/skin-conditions/dermatology-a-to-z/melanoma/signs-symptoms/melanoma-signs-and-symptoms

Page 3: Malignant Melanoma and CDKN2A Kate Coffin

Dangers of Melanoma

Leading cause of death due to skin disease

2012 estimates in US76,250 new cases9,180 deaths

National Cancer Institute http://www.cancer.gov/cancertopics/types/melanomahttp://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/snapshots

Page 4: Malignant Melanoma and CDKN2A Kate Coffin

Metastasis

Spreading to other areas of skin and other tissues

14% 5 year survival rate

Miller, A et al. (2006). Melanoma. The New England Journal of Medicine. 355(1), 51-65. PMID:16822996

Page 5: Malignant Melanoma and CDKN2A Kate Coffin

CDKN2A Cyclin-dependent kinase inhibitor 2A

Inhibits CDK4

Tumor Suppressor

>30 germline mutations

http://en.wikipedia.org/wiki/File:Protein_CDKN2A_PDB_1a5e.png

Page 6: Malignant Melanoma and CDKN2A Kate Coffin

CDKN2A Domains – Ankyrin repeats

Pfam SMART

Found in archaea, bacteria, eukarya, and poxviruesIn other proteins associated with human disease

http://smart.embl-heidelberg.de/http://pfam.sanger.ac.uk/

Page 7: Malignant Melanoma and CDKN2A Kate Coffin

CDKN2A Gene OntologyBiological Processes

- cell cycle arrest - cell cycle checkpoint- induction of apoptosis - negative regulation of cell growth

Cellular Components- nucleus - cytoplasm

Molecular Functions- cyclin-dependent kinase inhibitor - protein kinase binding

http://amigo.geneontology.org/cgi-bin/amigo/go.cgi

Page 8: Malignant Melanoma and CDKN2A Kate Coffin

CDKN2A Protein Phylogeny

http://www.ebi.ac.uk/Tools/msa/clustalw2/

Page 9: Malignant Melanoma and CDKN2A Kate Coffin

Human CDKN2A Interaction Network

http://string-db.org/

Page 10: Malignant Melanoma and CDKN2A Kate Coffin

Human CDKN2A Interaction Network

http://string-db.org/

Page 11: Malignant Melanoma and CDKN2A Kate Coffin

Human CDKN2A Interaction Network

http://string-db.org/

Page 12: Malignant Melanoma and CDKN2A Kate Coffin

Human CDK4 Interaction Network

http://string-db.org/

Page 13: Malignant Melanoma and CDKN2A Kate Coffin

CDK4 Domains – Protein Kinase

http://pfam.sanger.ac.uk/

Pfam

Conserved from E. coli to humansCatalytic component of Serine/Threonine kinases

Page 14: Malignant Melanoma and CDKN2A Kate Coffin

CDK4 Gene OntologyBiological Processes

- regulation of cell cycle - regulation of cell proliferation- signal transduction

Cellular Components- cyclin-dependent protein kinase holoenzyme complex- transcription factor complex

Molecular Functions- cyclin-dependent protein kinase activity - ATP bindinghttp://amigo.geneontology.org/cgi-bin/amigo/go.cgi

Page 15: Malignant Melanoma and CDKN2A Kate Coffin

Model of CDKN2A and CDK4

CDK4CDKN2A

Page 16: Malignant Melanoma and CDKN2A Kate Coffin

Model of CDKN2A and CDK4

CDK4CDKN2A

http://chungkitblog.files.wordpress.com/2012/01/ellen-family-visual-medium.jpg

Regulated Growth

Page 17: Malignant Melanoma and CDKN2A Kate Coffin

Model of CDKN2A and CDK4

CDK4CDKN2A

Page 18: Malignant Melanoma and CDKN2A Kate Coffin

Model of CDKN2A and CDK4

CDK4CDKN2A

http://upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Melanoma.jpg/250px-Melanoma.jpg

UnregulatedGrowth

Page 19: Malignant Melanoma and CDKN2A Kate Coffin

Model of CDKN2A and CDK4

CDK4CDKN2A

?

Page 20: Malignant Melanoma and CDKN2A Kate Coffin

Model of CDKN2A and CDK4

CDK4CDKN2A

?

http://chungkitblog.files.wordpress.com/2012/01/ellen-family-visual-medium.jpg

Regulated Growth

Page 21: Malignant Melanoma and CDKN2A Kate Coffin

QuestionCan I find a compound that mimics

CDKN2A by inhibiting CDK4?

Page 22: Malignant Melanoma and CDKN2A Kate Coffin

QuestionCan I find a compound that mimics

CDKN2A by inhibiting CDK4?

HypothesisIf a compound were known to interact with and

inhibit CDK4, it could be used as a drug for melanoma

Page 23: Malignant Melanoma and CDKN2A Kate Coffin

Experiment – Identify Compound

http://pubchem.ncbi.nlm.nih.gov/

Page 24: Malignant Melanoma and CDKN2A Kate Coffin

Results – Identify Compound

2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione

http://pubchem.ncbi.nlm.nih.gov/

Cdk4 Inhibitor III

Page 25: Malignant Melanoma and CDKN2A Kate Coffin

Results – Identify Compound

http://pubchem.ncbi.nlm.nih.gov/

Page 26: Malignant Melanoma and CDKN2A Kate Coffin

QuestionCan I find a compound that mimics

CDKN2A by inhibiting CDK4?

HypothesisIf a compound were known to interact with and

inhibit CDK4, it could be used as a drug for melanoma

HypothesisIf Cdk4 were inhibited by Cdk4 Inhibitor III in a Cdkn2a CKO mouse, the tumor cells would not proliferate and

metastasize

Page 27: Malignant Melanoma and CDKN2A Kate Coffin

Why choose a mouse?

Skin and vascular systems

Previous cancer model

Cdkn2a – Cdk4 interaction

http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg

Page 28: Malignant Melanoma and CDKN2A Kate Coffin

Why choose a mouse?

Skin and vascular systems

Previous cancer model

Cdkn2a – Cdk4 interaction

https://www.aalaslearninglibrary.org/fileupload_content/Course245/14_Nude_tumor.jpg

Page 29: Malignant Melanoma and CDKN2A Kate Coffin

Why choose a mouse?

Skin and vascular systems

Previous cancer model

Cdkn2a – Cdk4 interaction

http://string-db.org/

Page 30: Malignant Melanoma and CDKN2A Kate Coffin

Experiment – Treatment GroupsCdkn2a +/+

http://info.criver.com/flex_content_area/images/nude_mouse-2.jpghttp://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg

1

Page 31: Malignant Melanoma and CDKN2A Kate Coffin

Experiment – Treatment GroupsCdkn2a +/+ Cdkn2a -/- (CKO)

http://info.criver.com/flex_content_area/images/nude_mouse-2.jpghttp://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg

1 2

Page 32: Malignant Melanoma and CDKN2A Kate Coffin

Experiment – Treatment GroupsCdkn2a +/+ Cdkn2a -/- (CKO)

Cdkn2a +/+& Cdk4 Inhibitor III

http://info.criver.com/flex_content_area/images/nude_mouse-2.jpghttp://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg

1 2

3

Page 33: Malignant Melanoma and CDKN2A Kate Coffin

Experiment – Treatment GroupsCdkn2a +/+ Cdkn2a -/- (CKO)

Cdkn2a +/+& Cdk4 Inhibitor III

Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

http://info.criver.com/flex_content_area/images/nude_mouse-2.jpghttp://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg

1

43

2

Page 34: Malignant Melanoma and CDKN2A Kate Coffin

Experiment – Graft Human MelanomaCdkn2a +/+ Cdkn2a -/- (CKO)

Cdkn2a +/+& Cdk4 Inhibitor III

Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

https://www.aalaslearninglibrary.org/fileupload_content/Course245/14_Nude_tumor.jpghttp://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg

1

3 4

2

Page 35: Malignant Melanoma and CDKN2A Kate Coffin

Data Collection

Microarray analysis ofCdkn2a and Cdk4expression in cells of mice

https://commons.wikimedia.org/wiki/File:DNA_microarray.svg

Page 36: Malignant Melanoma and CDKN2A Kate Coffin

Expected Microarray Results1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

Left Well: Cdkn2a Right Well: Cdk4

Page 37: Malignant Melanoma and CDKN2A Kate Coffin

Expected Microarray Results1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

Left Well: Cdkn2a Right Well: Cdk4

Page 38: Malignant Melanoma and CDKN2A Kate Coffin

Expected Microarray Results1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

Left Well: Cdkn2a Right Well: Cdk4

Page 39: Malignant Melanoma and CDKN2A Kate Coffin

Expected Microarray Results1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

Left Well: Cdkn2a Right Well: Cdk4

Page 40: Malignant Melanoma and CDKN2A Kate Coffin

Expected Microarray Results1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

Left Well: Cdkn2a Right Well: Cdk4

Page 41: Malignant Melanoma and CDKN2A Kate Coffin

Expected Metastasis Results

1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

Page 42: Malignant Melanoma and CDKN2A Kate Coffin

Expected Metastasis Results

1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

LEAST METASTASIS

Page 43: Malignant Melanoma and CDKN2A Kate Coffin

Expected Metastasis Results

1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

MOST METASTASIS

LEAST METASTASIS

Page 44: Malignant Melanoma and CDKN2A Kate Coffin

Expected Metastasis Results

1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO)

3) Cdkn2a +/+& Cdk4 Inhibitor III

4) Cdkn2a -/- (CKO)& Cdk4 Inhibitor III

MOST METASTASIS

LEAST METASTASIS

MODERATE METASTASIS

MODERATE METASTASIS

Page 45: Malignant Melanoma and CDKN2A Kate Coffin

Conclusion

CDK4 Inhibitor III could be used as an antimelanoma drug by mimicking the tumor suppressor function of CDKN2A in patients with CDKN2A loss of function mutations

Page 46: Malignant Melanoma and CDKN2A Kate Coffin

Future Directions

Test other modes of drug administrationTopical cream vs Intravenous solution

Different dosages/times of administration

Study other proteins in interaction networkLook for other tumor suppressors

Study effects of UV exposure on CDKN2AHow does SPF affect this interaction?

Look for compounds in other mutated melanoma pathways

Page 47: Malignant Melanoma and CDKN2A Kate Coffin

Questions?

http://www.liuding.com/blog/uploaded_images/fig8-794407.jpg